Risk of cancer incidence in patient with idiopathic pulmonary fibrosis: An analysis of the National Health Insurance Service database of Korea
Conclusions: Patients with IPF had a higher risk for various types of cancer incidence compared to matched control cohort. Greater attention should be paid to cancer development and screening in patients with IPF.
PANCREATIC cancer symptoms are often non-specific and vague in the beginning. One of the first noticeable signs is associated with your stomach.
Publication date: Available online 20 September 2020Source: Biochimica et Biophysica Acta (BBA) - Reviews on CancerAuthor(s): Marjolein M.G. Kes, Jan Van den Bossche, Arjan W. Griffioen, Elisabeth J.M. Huijbers
Publication date: Available online 19 September 2020Source: Biochimica et Biophysica Acta (BBA) - Reviews on CancerAuthor(s): Hang-Ping Yao, Rachel Hudson, Ming-Hai Wang
Conclusion: Moderate quality evidence suggests that OMTh is effective for CNCP patients. There was a significant association between visceral OMTh and reduced pain severity and disability. More robust, high-quality randomized controlled trials with larger sample sizes are required to further explore the effectiveness of the OMTh in the management of CNCP. PMID: 32946545 [PubMed - as supplied by publisher]
Invasive breast cancer deriving from the milk duct and lobule that develops in the nipple is extremely rare, except in Paget ’s disease and skin cancer. This is the second reported case of the development of invasive cancer confined to the nipple after breast-conserving surgery. A 69-year-old woman visited our department due to redness, swelling, and bloody discharge of the right nipple in the last month. A needle biops y was suggestive of invasive ductal carcinoma; we performed a removal surgery of the right residual breast tissue and a second sentinel lymph node biopsy. She underwent these procedures 10 years previ...
Tumor lysis syndrome (TLS) is a hemato-oncological emergency characterized by metabolic and electrolyte imbalances which are associated with disintegrating tumor cells. The syndrome is frequently observed when starting cytotoxic treatment of hematological malignancies, while the incidence of spontaneous tumor lysis prior to the start of tumor therapy is rare. Here, we present a case of spontaneous TLS in a male patient who was referred with unspecific symptoms and suspected metastatic malignancy. He developed acute renal failure before the diagnosis of a high-grade B-cell lymphoma (double hit lymphoma) and start of therapy...
(Wiley) New research suggests that Black women experience longer waits for treatment initiation than white women after a breast cancer diagnosis, and their duration of treatment is prolonged. The findings are published early online in CANCER, a peer-reviewed journal of the American Cancer Society (ACS).
Lymphedema: Clinical Summary of the ONS Guidelines™ for Cancer Treatment-Related Lymphedema. Clin J Oncol Nurs. 2020 Oct 01;24(5):566-570 Authors: Backler C, Beck M, Poage E Abstract Secondary (acquired) lymphedema is a chronic condition lacking a known cure that most commonly results from cancer treatment, particularly for breast, gynecologic, prostate, and head and neck cancers; lymphoma; and melanoma, and affects an estimated 1 in 1,000 Americans. Lymphedema is characterized by an accumulation of protein-rich lymphatic fluid in the affected part of the body. It can potentially affect function...
Conclusions In this study, RNA-Seq analysis detected only 46-49% of pathogenic variants identifiable by sequencing of tumor DNA. Mutations were more often missed by RNA-Seq when present at low frequency or when tested on FNA samples. All TERT mutations were missed by RNA-Seq. These data suggest that RNA-Seq does not detect a significant proportion of clinically relevant mutations and should be used with caution in clinical practice for detecting DNA mutations. PMID: 32948110 [PubMed - as supplied by publisher]
More News: Cancer | Cancer & Oncology | Cancer of the Uterus | Cervical Cancer | Databases & Libraries | Health Insurance | Insurance | Leukemia | Liver | Lung Cancer | Lymphoma | Myeloma | Pancreas | Pancreatic Cancer | Prostate Cancer | Respiratory Medicine | Skin | Skin Cancer | Thyroid | Thyroid Cancer | Urology & Nephrology